Eli Lilly (LLY +3.3%) gets a boost when Sanford Bernstein analyst Tim Anderson notes that the...

|About: Eli Lilly and Company (LLY)|By:, SA News Editor

Eli Lilly (LLY +3.3%) gets a boost when Sanford Bernstein analyst Tim Anderson notes that the company's shares could rise 50%-100% if it scores a success with its Alzheimer's drugs. Though he rates the chances at only 10%-20% of the firm hitting the lottery with solanezumab, Anderson says if it does it will make Lipitor look like a "mid-sized product."